Alzheimer's Disease Clinical Trials in Long Beach, CA

44 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)	—	University of Southern California	<1 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies	Phase 3	Hoffmann-La Roche	<1 mi
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)	Phase 2	Merck Sharp & Dohme LLC	<1 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)	Phase 3	Bristol-Myers Squibb	<1 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)	Phase 3	Karuna Therapeutics	<1 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)	Phase 3	Bristol-Myers Squibb	<1 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease	Phase 3	Bristol-Myers Squibb	<1 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease	Phase 3	Hoffmann-La Roche	<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)	Phase 3	Karuna Therapeutics	7 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease	Phase 2	Celgene	7 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease	Phase 2	Intra-Cellular Therapies, Inc.	7 mi
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)	Phase 1	Eli Lilly and Company	7 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)	Phase 3	Bristol-Myers Squibb	10 mi
ACP-204 in Adults With Alzheimer's Disease Psychosis	Phase 2/3	ACADIA Pharmaceuticals Inc.	15 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia	Phase 2	Intra-Cellular Therapies, Inc.	15 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)	Phase 3	Bristol-Myers Squibb	16 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease	Phase 3	Hoffmann-La Roche	16 mi
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type	Phase 3	Suven Life Sciences Limited	17 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis	Phase 2	MapLight Therapeutics	17 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD	Phase 3	Annovis Bio Inc.	17 mi
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01	Phase 1	Alzheimer's Disease Expert Lab (ADEL), Inc.	17 mi
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Phase 2	University of Arizona	18 mi
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease	Phase 1	Regeneration Biomedical, Inc.	19 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)	Phase 2	Alzheimer's Disease Cooperative Study (ADCS)	19 mi
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease	Phase 1/2	NKGen Biotech, Inc.	19 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)	Phase 3	Karuna Therapeutics	20 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)	—	University of Southern California	20 mi
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders	N/A	University of Michigan	20 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol	—	Indiana University	20 mi
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD	Phase 1	Butler Hospital	20 mi
[18F]PI-2620 Phase 3 Histopathological Study	Phase 3	Life Molecular Imaging Ltd	20 mi
Polyphenols and Cognitive Decline	N/A	University of California, Los Angeles	20 mi
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)	Phase 1/2	University of California, Los Angeles	20 mi
Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.	N/A	University of Southern California	20 mi
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease	N/A	University of California, Los Angeles	20 mi
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study	N/A	Cedars-Sinai Medical Center	20 mi
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers	N/A	University of California, Los Angeles	20 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	20 mi
Cardiac-Control Affecting Learning Through Mindfulness (CALM)	N/A	University of Southern California	20 mi
Music-Based Interventions, Aging, Alzheimer's Disease	N/A	University of Southern California	20 mi
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions	Phase 1/2	Thomas Advanced Medical LLC	21 mi
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)	Phase 2	Merck Sharp & Dohme LLC	22 mi
Biomarker Exploration in Aging, Cognition and Neurodegeneration	Phase 3	University of California, Irvine	22 mi
Open-Label Extension Protocol to SNK01-AD01 Study	Phase 2	NKGen Biotech, Inc.	26 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.